The Blue Box raises €3M in a funding round led by Unconventional Ventures to advance its AI-powered urine-based breast cancer test.

Jul 10, 2025•6 days ago

Amount Raised

€3 Million

BarcelonaBiotechnologyHealth Care

Investors

Spanish Association Against CancerFoss/Krups FamilyHans(wo)man GroupGrow VenturesFund FUnconventional Ventures

Description

The Blue Box Biomedical Solutions has secured €3 million to fuel its clinical trial phase and achieve CE marking by the end of 2026. This medtech startup aims to revolutionize breast cancer screening with a non-invasive urine test powered by AI. The funding will help address the critical gap in early detection for women, especially those with dense breasts. Investors include Unconventional Ventures, Fund F, Grow Ventures, and more.

Company Information

Company

The Blue Box Biomedical Solutions

Location

Barcelona, Catalonia, Spain

About

The Blue Box Biomedical Solutions is a medtech startup focused on developing an innovative urine-based breast cancer screening test powered by AI. This technology aims to enhance early detection by leveraging chemical sensor systems to capture cancer-related volatile organic compounds in urine. The approach is designed to provide a non-invasive, radiation-free alternative to traditional mammography. The company is committed to making breast cancer screening more accessible and effective for women worldwide.

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

The Blue Box raises €3M in a funding round led by Unconventional Ventures to advance its AI-powered urine-based breast cancer test.

Investors

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Related People

Company Information